Aerovate Therapeutics, Inc.
Inhalable imatinib formulations, manufacture, and uses thereof
Last updated:
Abstract:
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Status:
Grant
Type:
Utility
Filling date:
14 May 2020
Issue date:
12 Apr 2022